New drug TAK-004 tested in humans for first time – no cure expected
NCT ID NCT06236009
First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 28 times
Summary
This study tested a new drug, TAK-004, in 121 healthy adults to see if it is safe and how the body handles it. Participants received either the drug or a placebo as an injection under the skin. The goal was to check for side effects, effects on heart rate and blood pressure, and whether the body makes antibodies against the drug. This is an early-stage study with no direct treatment benefit for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.